Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000480446 | SCV000564892 | likely pathogenic | not provided | 2021-07-31 | criteria provided, single submitter | clinical testing | Reported as a likely pathogenic variant in a healthy individual enrolled in a preconception carrier screening study (Capalbo A et al., 2019); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 31589614) |
Labcorp Genetics |
RCV000412175 | SCV000959655 | pathogenic | Cohen syndrome | 2023-08-28 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 370733). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. This variant is present in population databases (rs759536357, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Thr301Valfs*7) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV000480446 | SCV002497985 | pathogenic | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV000412175 | SCV003925152 | likely pathogenic | Cohen syndrome | 2022-06-06 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000412175 | SCV000486123 | likely pathogenic | Cohen syndrome | 2016-04-01 | no assertion criteria provided | clinical testing | |
Molecular Genetics Laboratory, |
RCV000412175 | SCV000803696 | pathogenic | Cohen syndrome | 2017-12-11 | no assertion criteria provided | clinical testing |